Recent News

• 12.01.2025 - Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC
• 11.28.2025 - REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC
• 11.27.2025 - Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC
• 11.26.2025 - Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
• 11.25.2025 - Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
• 11.07.2025 - Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern’ Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Recent Filings

• 12.01.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.01.2025 - EX-99.1 EX-99.1
• 11.28.2025 - EX-99.1 EX-99.1
• 11.28.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.26.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.26.2025 - EX-99.1 EX-99.1
• 11.25.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.25.2025 - EX-99.1 EX-99.1
• 11.07.2025 - EX-99.1 EX-99.1
• 11.07.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]